Increased platelet reactivity in HIV-1-infected patients receiving abacavir-containing antiretroviral therapy (Q57098021)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21917893%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

title

Increased platelet reactivity in HIV-1-infected patients receiving abacavir-containing antiretroviral therapy (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21917893%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21917893%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

Aaron J Peace

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21917893%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

Eileen O'Connor

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21917893%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

Eoin R Feeney

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21917893%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

Dermot Kenny

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21917893%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

author name string

Claudette S Satchell

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21917893%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

Aoife G Cotter

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21917893%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

Anthony F Tedesco

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21917893%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

John S Lambert

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21917893%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

Gerard J Sheehan

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21917893%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

Patrick W G Mallon

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21917893%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

language of work or name

English

0 references

publication date

1 October 2011

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21917893%20AND%20SRC:MED&resulttype=core&format=json

Journal of Infectious Diseases

12 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21917893%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

volume

204

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21917893%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

issue

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21917893%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

page(s)

1202-1210

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21917893%20AND%20SRC:MED&resulttype=core&format=json

Life expectancy of individuals on combination antiretroviral therapy in high-income countries: a collaborative analysis of 14 cohort studies

12 February 2020

cites work

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIR509

A syndrome of peripheral lipodystrophy, hyperlipidaemia and insulin resistance in patients receiving HIV protease inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIR509

Association between protease inhibitor use and increased cardiovascular risk in patients infected with human immunodeficiency virus: a systematic review.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIR509

Cardiovascular disease risk factors in HIV patients--association with antiretroviral therapy. Results from the DAD study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIR509

Class of Antiretroviral Drugs and the Risk of Myocardial Infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIR509

Use of nucleoside reverse transcriptase inhibitors and risk of myocardial infarction in HIV-infected patients enrolled in the D:A:D study: a multi-cohort collaboration

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIR509

Less lipoatrophy and better lipid profile with abacavir as compared to stavudine: 96-week results of a randomized study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIR509

Use of nucleoside reverse transcriptase inhibitors and risk of myocardial infarction in HIV-infected patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIR509

Abacavir and risk of myocardial infarction in HIV-infected patients on highly active antiretroviral therapy: a population-based nationwide cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIR509

Simplification of antiretroviral therapy with tenofovir-emtricitabine or abacavir-Lamivudine: a randomized, 96-week trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIR509

Impact of individual antiretroviral drugs on the risk of myocardial infarction in human immunodeficiency virus-infected patients: a case-control study nested within the French Hospital Database on HIV ANRS cohort CO4.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIR509

Risk of myocardial infarction and abacavir therapy: no increased risk across 52 GlaxoSmithKline-sponsored clinical trials in adult subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIR509

Inflammation in atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIR509

Platelet activation and atherothrombosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIR509

Inflammation, atherosclerosis, and coronary artery disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIR509

Platelet hyperactivity and risk of recurrent thrombosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIR509

Increased risk in patients with high platelet aggregation receiving chronic clopidogrel therapy undergoing percutaneous coronary intervention: is the current antiplatelet therapy adequate?

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIR509

Platelet reactivity in patients and recurrent events post-stenting: results of the PREPARE POST-STENTING Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIR509

Platelet function and HIV: a case-control study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIR509

Using standardized serum creatinine values in the modification of diet in renal disease study equation for estimating glomerular filtration rate

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIR509

Monitoring modulators of platelet aggregation in a microtiter plate assay

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIR509

Dual antiplatelet therapy unmasks distinct platelet reactivity in patients with coronary artery disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIR509

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIR509

Guanylate cyclase and the .NO/cGMP signaling pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIR509

Nitric oxide-independent stimulation of soluble guanylate cyclase with BAY 41-2272 in cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIR509

Association of abacavir and impaired endothelial function in treated and suppressed HIV-infected patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIR509

Effects of VLDL and remnant particles on platelets

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIR509

Association of Blood Pressure With Fibrinolytic Potential in the Framingham Offspring Population

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIR509

Longitudinal evaluation of cardiovascular disease-associated biomarkers in relation to abacavir therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIR509

Inflammatory biomarkers and abacavir use in the Women's Interagency HIV Study and the Multicenter AIDS Cohort Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIR509

Renal function and risk of myocardial infarction in an elderly population: the Rotterdam Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIR509

21 January 2018

Identifiers

DOI

10.1093/INFDIS/JIR509

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21917893%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

1 reference